Background Few data are available on thrombotic outcomes during pregnancy and
puerperium occurring after an initial provoked venous thromboembolic (VTE) event …

Background Women of childbearing age are exposed to venous thromboembolic risk mainly
for pregnancy and use of oral contraceptives. The impact of risk factors (RF) on venous …

BACKGROUND: Combined oral contraceptives (COC) increase the risk of venous
thromboembolism (VTE), but the risk of recurrent VTE is not precisely determined. In this …

Objective While the majority of venous thromboembolism (VTE) during pregnancy events
resolve with anticoagulation, long-term complications may occur including (1) …

Objective Combined oral contraceptives (COCs) are used for various reasons. However,
venous thromboembolism (VTE), a significant side effect, can be fatal. This study reports the …

The risk of recurrence after discontinuation of anticoagulation for a combined oral
contraceptive (COC)‐associated venous thromboembolism (VTE) is unclear. Therefore, we …

Hormonal contraception is the most popular and effective reversible method for preventing
unwanted pregnancy exerting multiple prophylactic and therapeutic effect along with …

Background: An association between oral contraceptive (OC) use and venous
thromboembolism (VTE) has long been recognized. However, no summary estimates of the …

Methods: Two researchers independently ran a thorough search in Pubmed, ISI Web of
Science, EMBASE, CINAHL and Scopus databases regarding study keywords including …

Essentials• We performed a meta‐analysis on thrombosis risk in thrombophilic oral
contraceptive (COC)‐users.• The results support discouraging COC‐use in women with a …